scholarly journals Heroin-induced Ulcer Mimicking Pyoderma Gangrenosum

2021 ◽  
Vol 5 (4) ◽  
pp. 414-417
Author(s):  
Deep Patel ◽  
Jennifer Mardini ◽  
Christopher Chu ◽  
Max Disse ◽  
Alexandra Flamm

Subcutaneous injections of illicit substances may be performed by some patients citing several advantages by the user, and can present to clinic with ulcers that clinically mimic pyoderma gangrenosum. However, it is vital to recognize heroin-induced ulcers and treat urgently to preserve function. Treatment requires a multidisciplinary approach with general medicine, dermatology, plastic surgery, wound care, infectious disease and addiction medicine. We present a patient with lower extremity ulceration due to subcutaneous injection of heroin which resembled PG.

2018 ◽  
Vol 6 ◽  
pp. 2050313X1878304 ◽  
Author(s):  
Mildred Lopez Pineiro ◽  
Eric Willis ◽  
Chen Yao ◽  
Susan Y Chon

Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor used for the treatment of multiple different types of malignancies. Serious grade 3–4 adverse events occur in <10% of the patient population and usually improve with dose reduction. One of the more rarely reported side effects of sunitinib therapy is the development of pyoderma gangrenosum–like ulcerations in the lower extremities. These pyoderma gangrenosum–like ulcerations are difficult to treat and distinguish from similar-appearing dermatological diagnoses. We present a patient with refractory lung carcinoma and a past medical history of squamous cell carcinoma of the lower extremity, who developed a non-healing ulceration at the previous site of her skin cancer while undergoing therapy with sunitinib. At the time of the initial evaluation, the ulceration mimicked recurrent squamous cell carcinoma, posing a diagnostic challenge. Histopathological findings showed epidermal hyperplasia, ulceration, and dense acute inflammation. Despite meticulous wound care and treatment of infection, the ulcer only improved with cessation of sunitinib.


2021 ◽  
pp. 074873042098732
Author(s):  
N. Kronfeld-Schor ◽  
T. J. Stevenson ◽  
S. Nickbakhsh ◽  
E. S. Schernhammer ◽  
X. C. Dopico ◽  
...  

Not 1 year has passed since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19). Since its emergence, great uncertainty has surrounded the potential for COVID-19 to establish as a seasonally recurrent disease. Many infectious diseases, including endemic human coronaviruses, vary across the year. They show a wide range of seasonal waveforms, timing (phase), and amplitudes, which differ depending on the geographical region. Drivers of such patterns are predominantly studied from an epidemiological perspective with a focus on weather and behavior, but complementary insights emerge from physiological studies of seasonality in animals, including humans. Thus, we take a multidisciplinary approach to integrate knowledge from usually distinct fields. First, we review epidemiological evidence of environmental and behavioral drivers of infectious disease seasonality. Subsequently, we take a chronobiological perspective and discuss within-host changes that may affect susceptibility, morbidity, and mortality from infectious diseases. Based on photoperiodic, circannual, and comparative human data, we not only identify promising future avenues but also highlight the need for further studies in animal models. Our preliminary assessment is that host immune seasonality warrants evaluation alongside weather and human behavior as factors that may contribute to COVID-19 seasonality, and that the relative importance of these drivers requires further investigation. A major challenge to predicting seasonality of infectious diseases are rapid, human-induced changes in the hitherto predictable seasonality of our planet, whose influence we review in a final outlook section. We conclude that a proactive multidisciplinary approach is warranted to predict, mitigate, and prevent seasonal infectious diseases in our complex, changing human-earth system.


2014 ◽  
Vol 2014 ◽  
pp. 1-4
Author(s):  
Derek To ◽  
Aaron Wong ◽  
Valentina Montessori

We present a patient with atypical pyoderma gangrenosum (APG), which involved the patient’s arm and hand. Hemorrhagic bullae and progressive ulcerations were initially thought to be secondary to an infectious process, but a biopsy revealed PG. Awareness of APG by infectious disease services may prevent unnecessary use of broad-spectrum antibiotics.


2002 ◽  
Vol 92 (1) ◽  
pp. 54-58
Author(s):  
Harry Goldsmith ◽  
Matthew G. Garoufalis

This article describes the treatment of lower-extremity wounds, specifically foot and ankle ulcerations, in the context of reimbursement for treatments rendered. Therefore, such issues as standard of care, documentation, classification of foot wounds, coding, and reimbursement are discussed. (J Am Podiatr Med Assoc 92(1): 54-58, 2002)


2021 ◽  
pp. 153857442110462
Author(s):  
Ahmed A. Sorour ◽  
Levester Kirksey ◽  
Sarah Keller ◽  
Michael S. O’Connor ◽  
Sean P. Lyden

Catastrophic antiphospholipid syndrome (CAPS) is a rare life threatening presentation of antiphospholipid syndrome. Surgery has been proposed as one of the triggering factors for this life threatening entity. There are no detailed published reports in the current literature describing CAPS as a complication after surgery. We report a case of a 21 year old that developed CAPS postoperatively and discuss the multidisciplinary approach for diagnosis and management.


2018 ◽  
Author(s):  
Anil Hingorani

The diabetic foot is a commonly encountered problem in surgical practice. Since treatment of the diabetic foot is quite complex, its management can mandate a multidisciplinary approach, including vascular surgery, acute care surgery, intensive care, podiatry, internal medicine, endocrinology, infectious disease, nursing, case management, and social work. This review highlights some of the details of the management of the diabetic foot from such an approach. This review contains 1 figure and 21 referencesKey words: diabetic foot ulcer, infection, ischemia, off-loading, revascularization


2017 ◽  
Vol 1 (1) ◽  
pp. 1-5
Author(s):  
Naresh Kumar Ghodela ◽  
Tukaram Dudhamal

Ulcers in lower extremity are generally caused by venous insufficiency, arterial insufficiency, and diabetic neuropathy. Inflammatory ulcers are also difficult to diagnose because of underlying pathophysiology rests on inflammation and immunologic phenomena. Definitive diagnosis and multidisciplinary treatment approach are needed to manage lower extremity ulcers. These ulcers may hamper the quality of life of patient. Here we reported a new case of post fracture of shaft of right tibia bone, presented with painful, hypertrophied, irregular shaped ulcer on anterior aspect of tibia gradually developing since 3 months. A male patient of 45 years old consulted to OPD with above complaint that was unable to bear weight on the effected leg (right limb). This case was managed with a local application of Thumari Gel and ulcers were almost healed within 6 weeks of wound care along with internal use of Ayurveda medicines. This case concluded that regular local application of Thumari Gel helpful in healing of chronic ulcer.


1923 ◽  
Vol 38 (2) ◽  
pp. 149-161 ◽  
Author(s):  
Russell L. Cecil ◽  
Gustav I. Steffen

1. Three subcutaneous injections of Pneumococcus Type II vaccine confer on monkeys a complete immunity against experimental Pneumococcus Type II pneumonia. A similar protection can be bestowed on monkeys against Pneumonococcus Type IV pneumonia by three subcutaneous injections of a vaccine prepared from the same strain of pneumococcus. 2. The subcutaneous injection of monkeys with three doses of Pneumococcus Type III vaccine confers a complete immunity against this type in only 50 per cent of cases (four out of eight monkeys vaccinated). 3. In spite of the immunity induced in monkeys by three subcutaneous injections of Pneumococcus Types II, III, and IV vaccine, specific protective bodies against the homologous types are not demonstrable in their serums when the vaccine is so administered.


2018 ◽  
Author(s):  
Anil Hingorani

The diabetic foot is a commonly encountered problem in surgical practice. Since treatment of the diabetic foot is quite complex, its management can mandate a multidisciplinary approach, including vascular surgery, acute care surgery, intensive care, podiatry, internal medicine, endocrinology, infectious disease, nursing, case management, and social work. This review highlights some of the details of the management of the diabetic foot from such an approach. This review contains 1 figure and 21 referencesKey words: diabetic foot ulcer, infection, ischemia, off-loading, revascularization


Sign in / Sign up

Export Citation Format

Share Document